Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://antonesas202779.win-blog.com/19998548/trelaglutide-exploring-a-new-option-for-chronic-diseases